End2Cancer Conference

November 20-22, 2019
Oklahoma City, OK
Hosted by the Stephenson Cancer Center

About the Conference

The University of Oklahoma Health Sciences Center and the NCI-Designated Stephenson Cancer Center are proud to host the 2019 END2CANCER: Emerging Nanotechnology and Drug Delivery Applications for Cancer conference in conjunction with a one-day Hands-on Workshop in Nanotechnology from November 20-22, 2019 in Oklahoma City, Oklahoma, USA.

The conference will bridge laboratory research conducted in the areas of nanotechnology and drug delivery to clinical application for the detection, diagnosis, imaging and treatment of cancer. The conference will host keynote, plenary and invited lectures by eminent scientists who will discuss new and emerging concepts, technologies and challenges in translating nanomedicine from bench-to-bedside. A patient advocate will present special talk on the applications of nanomedicine for myeloma.

Topics discussed in the planned thematic sessions include Gene and Drug Delivery, Dug Discovery and Applications, Theranostics, Nanoimmuno-Oncology, Extracellular Vesicles, Genome Editing, and RNA and Protein Delivery. The multi-disciplinary two-day conference will bring together physicians, basic scientists, engineers, physicists, chemists, post-doctoral fellows, high-school and college students, patient advocates, business professionals, educators and technology transfer specialists.

Students and fellows will have an opportunity to present their work and compete for four cash awards. A special session titled “Art of Science in Light of Nanomedicine” will allow participants to display their best research as a photo with a caption and compete for cash award.

Hands-On Workshop for High School Seniors

The focus of the Hands-on Workshop in Nanotechnology is for High School Senior students from the state of Oklahoma who are interested in Science, Technology, Engineering, and Math (STEM) programs and interested in pursuing a career in STEM fields. The workshop will enable students to understand the fundamental concepts of nanomedicine and their application to cancer. The curriculum for the workshop is designed by experts in the field of nanotechnology. The workshop will be held on November 20, 2019 from 8 am to 3 pm.

 

Art of Science in Light of Nanomedicine Photo Competition

Display your best research as a photo with a caption and compete for cash awards!

Guidelines:

  • Print on glossy, canvas, or any other material of your choice.
  • Size – 8×11 inches
  • Caption – any catchy phrase depicting the photo.
 
 

Registration & Call for Abstracts

 

Registration for the 2019 conference will open on Aug. 1, 2019. Please check back for the registration link at that time. There is no cost to register for the conference, but you will need to register to attend the conference.

 

 

Our call for Abstracts open Aug. 1, 2019. Please include the following with your proposal submission:

 

Title
Authors Names and Affiliations
Abstract Limit: 300 Words Max
Presenting Author: Underline
Presenting Author: Email
Font: Times New Roman
Font Size: 12
Acknowledgement of Funding

 

Committee Chairman & Co-Chairs

Planning Committee

Planning Committee

Conference Sponsors

CONFERENCE LOCATION

Samis Education Center
Located in The Children’s Hospital at OU Medicine on the Oklahoma Health Center Campus
1200 Children’s Ave
Oklahoma City, OK 73104

Parking & Directions

Parking is available for out-of-town guests. Please use the Events Parking Lot at The Children’s Hospital. If you are an employee of the OU Health Sciences Center, please use your normal parking lot.

The Samis Education Center is located just a few blocks north of the Stephenson Cancer Center and the Embassy Suites Hotel.

About the Stephenson Cancer Center

Oklahoma’s only comprehensive academic cancer center, the Stephenson Cancer Center at the University of Oklahoma is a nationally noted leader in research and patient care. The Stephenson Cancer Center annually ranks among the top three cancer centers in the nation for patients participating in National Cancer Institute-sponsored treatment trials, and it is one of 30 designated lead centers nationally in the Institute’s National Clinical Trials Network. In collaboration with the Oklahoma Tobacco Settlement Endowment Trust, the Stephenson Cancer Center is decreasing the burden of cancer in Oklahoma by supporting innovative laboratory, clinical and populations-based research. The Stephenson Cancer Center has 250 research members who are conducting more than 215 cancer research projects at institutions across Oklahoma. This research is supported by $48.3 million in annual funding from the National Cancer Institute, the American Cancer Society and other sponsors.

The University of Oklahoma is an equal opportunity institution. www.ou.edu/eoo